Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical complementology: recent progress and future trends.

× No keyword cloud information.

9 in total

1. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.

Authors: Imre Farkas; Lajos Baranyi; Yasushige Ishikawa; Noriko Okada; Csaba Bohata; Denes Budai; Atsuo Fukuda; Masaki Imai; Hidechika Okada
Journal: J Physiol Date: 2002-03-01 Impact factor: 5.182

Review 2. The future use of complement inhibitors for the treatment of neurological diseases.

Authors: E G McGeer; P L McGeer
Journal: Drugs Date: 1998-06 Impact factor: 9.546

3. Conformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entry.

Authors: Antonis Mirsaliotis; Kulpash Nurkiyanova; Daniel Lamb; Jenny M Woof; David W Brighty
Journal: J Virol Date: 2007-03-21 Impact factor: 5.103

4. Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection.

Authors: P Koraka; C Suharti; T E Setiati; A T Mairuhu; E Van Gorp; C E Hack; M Juffrie; J Sutaryo; G M Van Der Meer; J Groen; A D Osterhaus
Journal: J Clin Microbiol Date: 2001-12 Impact factor: 5.948

Clinical complementology: recent progress and future trends.

1. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.

Review 2. The future use of complement inhibitors for the treatment of neurological diseases.

3. Conformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entry.

4. Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection.

5. Solution structure of Compstatin, a potent complement inhibitor.

6. Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration.

7. A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement.

Review 8. Complement activation and cardiac surgery: a novel target for improving outcomes.

Review 9. Complement-specific antibodies: designing novel anti-inflammatories.